CANbridge Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 0/6
CANbridge Pharmaceuticals has a total shareholder equity of CN¥-280.2M and total debt of CN¥45.8M, which brings its debt-to-equity ratio to -16.3%. Its total assets and total liabilities are CN¥248.9M and CN¥529.2M respectively.
Key information
-16.3%
Debt to equity ratio
CN¥45.81m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥49.10m |
| Equity | -CN¥280.24m |
| Total liabilities | CN¥529.19m |
| Total assets | CN¥248.95m |
Recent financial health updates
No updates
Recent updates
CANbridge Pharmaceuticals Inc. (HKG:1228) Not Doing Enough For Some Investors As Its Shares Slump 28%
Nov 14
CANbridge Pharmaceuticals Inc. (HKG:1228) Stock Catapults 31% Though Its Price And Business Still Lag The Industry
Sep 27Lacklustre Performance Is Driving CANbridge Pharmaceuticals Inc.'s (HKG:1228) 28% Price Drop
Aug 07CANbridge Pharmaceuticals Inc.'s (HKG:1228) Share Price Boosted 56% But Its Business Prospects Need A Lift Too
Apr 23CANbridge Pharmaceuticals Inc.'s (HKG:1228) 26% Dip In Price Shows Sentiment Is Matching Earnings
May 05Financial Position Analysis
Short Term Liabilities: 1228 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: 1228 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1228 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: 1228's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1228 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 1228 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.2% each year